Jerzy Starak (#773)
- $ 6 B
- Pharmaceuticals
- Poland
- M
- 78 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Jerzy Starak is the owner of Polpharma, one of Poland's largest drug manufacturers. Polpharma specializes in pharmaceuticals used in cardiology, neurology and gastroenterology. Starak also founded and owns Polpharma Biologics, an arm of his company that focuses on developing biosimilar drugs. A diversified investor, Starak also holds a stake in herbal product producer Herbapol. Starak started out with chemical company Comindex in the 1970s.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Jerzy Starak’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Jerzy Starak’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $5.5B
(May 4, 2026)
© Iconic Billionaires